ADI vs COLL · P/E 61, rev $11.02B vs P/E 17, rev $181.9M
Analog Devices Inc (ADI) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Analog Devices Inc (ADI) is a semiconductors company listed on NASDAQ.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ADI revenue for 2025-11-01 was $11.02B. Net income was $2.27B. ADI currently screens at market cap $201.87B and trailing P/E 61.5.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
ADI currently screens at market cap $201.87B and trailing P/E 61.5. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the ADI and COLL stock pages for the full models.
Not investment advice.